We are live on ! Find out more
ADPT icon

Adaptive Biotechnologies
ADPT

226 hedge funds and large institutions have $1.18B invested in Adaptive Biotechnologies in 2023 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 85 increasing their positions, 63 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

650% more call options, than puts

Call options by funds: $2.73M | Put options by funds: $364K

35% more repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 63

18% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 22

17% more capital invested

Capital invested by funds: $1.01B → $1.18B (+$173M)

1% more funds holding

Funds holding: 223 → 226 (+3)

0.54% more ownership

Funds ownership: 92.84% → 93.39% (+0.54%)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
226
Holders Change
+3
Holders Change %
+1.35%
% of All Funds
3.6%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
26
Increased
85
Reduced
63
Closed
22
Calls
$2.73M
Puts
$364K
Net Calls
+$2.37M
Net Calls Change
-$8.85M

Top Buyers

Rank Fund Capital Flow
1
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$11M
2
GGHC
Gilder Gagnon Howe & Co
New York
+$10.3M
3
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$8.15M
4
B
Braidwell
Connecticut
+$5.72M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$5.54M

Top Sellers

Rank Fund Capital Flow
1
BG
Bellevue Group
Switzerland
-$22.6M
2
Millennium Management
Millennium Management
New York
-$8.12M
3
Morgan Stanley
Morgan Stanley
New York
-$6.12M
4
BlackRock
BlackRock
New York
-$5.34M
5
SIG
Senator Investment Group
New York
-$4.41M
Name Holding Trade Value Shares
Change 		Change in
Stake
Norges Bank
26
Norges Bank
Norway
$7.12M -$2.42M -274,249 -25%
Citadel Advisors
27
Citadel Advisors
Florida
$7.09M +$2.29M +259,225 +48%
Prudential Financial
28
Prudential Financial
New Jersey
$6.76M +$5.3M +601,150 +365%
American Century Companies
29
American Century Companies
Missouri
$6.51M +$1.41M +159,372 +28%
Morgan Stanley
30
Morgan Stanley
New York
$6.3M -$6.12M -693,768 -49%
B
31
Braidwell
Connecticut
$5.73M +$5.72M +648,451 New
Deutsche Bank
32
Deutsche Bank
Germany
$5.61M +$109K +12,345 +2%
Neuberger Berman Group
33
Neuberger Berman Group
New York
$5.5M -$72.6K -8,230 -1%
JP Morgan Chase
34
JP Morgan Chase
New York
$4.63M +$1.06M +120,353 +30%
Nordea Investment Management
35
Nordea Investment Management
Sweden
$4.51M +$4.59M +521,009 New
SIG
36
Senator Investment Group
New York
$4.42M -$4.41M -500,000 -50%
Schroder Investment Management Group
37
Schroder Investment Management Group
United Kingdom
$4.18M – – –
PCM
38
Peregrine Capital Management
Minnesota
$4.13M +$1.76M +199,764 +75%
Bank of America
39
Bank of America
North Carolina
$3.93M +$2.68M +303,851 +215%
Ameriprise
40
Ameriprise
Minnesota
$3.78M +$521K +59,064 +16%
TCM
41
Tekla Capital Management
Massachusetts
$3.73M – – –
Renaissance Technologies
42
Renaissance Technologies
New York
$3.48M -$192K -21,800 -5%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$3.37M -$91.3K -10,356 -3%
AG
44
Algert Global
California
$3.26M +$676K +76,638 +26%
PIM
45
Platinum Investment Management
Australia
$3.23M – – –
Voloridge Investment Management
46
Voloridge Investment Management
Florida
$2.97M -$627K -71,067 -17%
BCP
47
Berylson Capital Partners
Massachusetts
$2.38M -$174K -19,726 -7%
D.E. Shaw & Co
48
D.E. Shaw & Co
New York
$2.01M +$983K +111,547 +96%
Cerity Partners
49
Cerity Partners
New York
$1.94M +$542K +61,523 +39%
Swiss National Bank
50
Swiss National Bank
Switzerland
$1.91M -$225K -25,500 -11%
1
2
3 4 5

ADPT Hedge Fund Activity: Q1 2023 in Review

226 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Adaptive Biotechnologies (ADPT) for Q1 2023, worth a combined $1.18B — up 17% from $1.01B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ADPT positions and 22 closed out — a net gain of 4 holders — while 85 added to existing stakes and 63 trimmed.

The largest buyer was Pictet Asset Management (Switzerland), adding an estimated $11M. The largest seller was Bellevue Group, exiting entirely with an estimated $22.6M sold.

  • 226 institutional investors held Adaptive Biotechnologies (ADPT) as of Q1 2023, up from 223 in Q4 2022.
  • Funds reported $1.18B of Adaptive Biotechnologies stock for Q1 2023, up 17% quarter-over-quarter.
  • 26 funds opened new Adaptive Biotechnologies positions in Q1 2023 and 22 closed out, a net change of +4 holders.
  • The largest Adaptive Biotechnologies buyer in Q1 2023 was Pictet Asset Management (Switzerland), an estimated $11M added.
  • The largest Adaptive Biotechnologies seller in Q1 2023 was Bellevue Group, an estimated $22.6M sold.

Based on aggregated 13F filings for Q1 2023.